GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » Accounts Payable

G.Barekat Pharm (XTEH:BRKT1) Accounts Payable : IRR7,652,478 Mil (As of Mar. 2017)


View and export this data going back to 2017. Start your Free Trial

What is G.Barekat Pharm Accounts Payable?

G.Barekat Pharm's Accounts Payable for the quarter that ended in Mar. 2017 was IRR7,652,478 Mil.

G.Barekat Pharm's quarterly Accounts Payable stayed the same from . 20 (IRR0 Mil) to Mar. 2016 (IRR0 Mil) but then increased from Mar. 2016 (IRR0 Mil) to Mar. 2017 (IRR7,652,478 Mil).

G.Barekat Pharm's annual Accounts Payable stayed the same from . 20 (IRR0 Mil) to Mar. 2016 (IRR0 Mil) but then increased from Mar. 2016 (IRR0 Mil) to Mar. 2017 (IRR7,652,478 Mil).


G.Barekat Pharm Accounts Payable Historical Data

The historical data trend for G.Barekat Pharm's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G.Barekat Pharm Accounts Payable Chart

G.Barekat Pharm Annual Data
Trend Mar16 Mar17
Accounts Payable
- 7,652,478.00

G.Barekat Pharm Semi-Annual Data
Mar16 Mar17
Accounts Payable - 7,652,478.00

G.Barekat Pharm Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


G.Barekat Pharm Accounts Payable Related Terms

Thank you for viewing the detailed overview of G.Barekat Pharm's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


G.Barekat Pharm (XTEH:BRKT1) Business Description

Traded in Other Exchanges
N/A
Address
No. 11, 5th Alley, Bucharest Avenue, Argentina Square, Tehran, IRN
G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

G.Barekat Pharm (XTEH:BRKT1) Headlines

No Headlines